BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3292313)

  • 1. Frequency and specificity of protamine antibodies in diabetic and control subjects.
    Nell LJ; Thomas JW
    Diabetes; 1988 Feb; 37(2):172-6. PubMed ID: 3292313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
    Kurtz AB; Gray RS; Markanday S; Nabarro JD
    Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine antibody production in diabetic subjects treated with NPH insulin.
    Ellerhorst JA; Comstock JP; Nell LJ
    Am J Med Sci; 1990 May; 299(5):298-301. PubMed ID: 2337121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine.
    Weiss ME; Nyhan D; Peng ZK; Horrow JC; Lowenstein E; Hirshman C; Adkinson NF
    N Engl J Med; 1989 Apr; 320(14):886-92. PubMed ID: 2648147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
    Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
    Zöllner H; Jouni R; Panzer S; Khadour A; Janzen L; Wesche J; Ten Berg M; Schellong S; Heinken A; Greinacher A; Bakchoul T
    J Thromb Haemost; 2017 Jan; 15(1):176-184. PubMed ID: 27759896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced reactivity towards anti-protamine antibodies of a low molecular weight protamine analogue.
    Tsui B; Singh VK; Liang JF; Yang VC
    Thromb Res; 2001 Mar; 101(5):417-20. PubMed ID: 11297758
    [No Abstract]   [Full Text] [Related]  

  • 8. Protamine-induced fatal anaphylaxis. Prevalence of antiprotamine immunoglobulin E antibody.
    Sharath MD; Metzger WJ; Richerson HB; Scupham RK; Meng RL; Ginsberg BH; Weiler JM
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):86-90. PubMed ID: 3892171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial immunological investigations in a patient who had a life-threatening reaction to intravenous protamine.
    Weiss ME; Chatham F; Kagey-Sobotka A; Adkinson NF
    Clin Exp Allergy; 1990 Nov; 20(6):713-20. PubMed ID: 1707334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men.
    Adourian U; Shampaine EL; Hirshman CA; Fuchs E; Adkinson NF
    Anesthesiology; 1993 Feb; 78(2):368-72. PubMed ID: 8439034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis to protamine masquerading as an insulin allergy.
    Kim R
    Del Med J; 1993 Jan; 65(1):17-23. PubMed ID: 8454092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity of protamine preparations used to reverse heparin anticoagulation.
    Adourian UA; Hirshman CA; Adkinson NF; Weiss ME
    Anesthesiology; 1990 Aug; 73(2):328-31. PubMed ID: 2382853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine-containing insulin but not analog insulin and duration of insulin use are risk factors for the production of insulin autoantibodies in insulin-treated patients with diabetes mellitus.
    Nishimura H; Iizuka K; Takeda J
    Endocr J; 2014; 61(6):635-40. PubMed ID: 24681758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human protamines.
    Stanker LH; Wyrobek A; Balhorn R
    Hybridoma; 1987 Jun; 6(3):293-303. PubMed ID: 3596614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single doses of intravenous protamine result in the formation of protamine-specific IgE and IgG antibodies.
    Nyhan DP; Shampaine EL; Hirshman CA; Hamilton RG; Frank SM; Baumgartner WA; Adkinson NF
    J Allergy Clin Immunol; 1996 Apr; 97(4):991-7. PubMed ID: 8655896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of protamine sulfate in diabetics undergoing cardiac catheterization.
    Reed DC; Gascho JA
    Cathet Cardiovasc Diagn; 1988; 14(1):19-23. PubMed ID: 3349513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protamine-reactive natural IgM antibodies in human sera. Characterization of the epitope demonstrates specificity of antigenic recognition; occurrence indicates obscurity of origin and function.
    Rodman TC; Pruslin FH; Chauhan Y; To SE; Winston R
    J Exp Med; 1988 Mar; 167(3):1228-46. PubMed ID: 2450952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations.
    Vincent GM; Janowski M; Menlove R
    Cathet Cardiovasc Diagn; 1991 Jul; 23(3):164-8. PubMed ID: 1831070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ELISA detection of protamine antibodies].
    Junker M; Hobler H; Federlin K
    Immun Infekt; 1985 Apr; 13(2):80-2. PubMed ID: 3888823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.